Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyD. Ross Camidge, Alice T. Shaw, Yung‐Jue Bang et al.|The Lancet Oncology|2012Cited by 1.3k
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study GroupFrank V. Fossella, Chandra P. Belani, K. Mattson et al.|Journal of Clinical Oncology|2003Cited by 943
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsDavid P. Ryan, Joseph P. Eder, James C. Cusack et al.|Cancer|2006Cited by 49